[Impact of chronic Chlamydia pneumoniae infection on left ventricular remodeling after myocardial infarction]

Marcin Marcinkowski1, Danuta Czarnecka, Marek Jastrzebski

  • 1I Klinika Kardiologii, Collegium Medicum Uniwersytetu Jagiellońskiego, Kraków.

Przeglad Lekarski
|July 24, 2007
PubMed

Insights

Chronic Chlamydia pneumoniae infection is linked to altered left ventricular remodeling after myocardial infarction. This infection may worsen heart chamber changes, impacting recovery and long-term cardiac function.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Post-myocardial infarction (MI) left ventricular remodeling is influenced by inflammation and myocardial structural changes.
  • Chlamydia pneumoniae (Chp) infection can cause chronic myocyte infection, affecting apoptosis and TNF-alpha production.
  • Chp may induce cross-reactivity with alpha-myosin, potentially modulating cellular and organ-level remodeling.

Purpose of the Study:

  • To investigate the impact of chronic Chlamydia pneumoniae infection on left ventricular remodeling following myocardial infarction.
  • To evaluate the association between Chp serological markers and echocardiographic changes in left ventricular volume post-MI.

Main Methods:

  • 101 patients with a first myocardial infarction were enrolled.
  • Serological evidence of Chp infection was assessed using ELISA.
  • Left ventricular volumes were measured echocardiographically at 10 days and 10 weeks post-MI.

Main Results:

  • Patients with chronic Chp infection showed a trend towards higher end-diastolic volume at 10 weeks post-MI (p=0.09).
  • ROC analysis identified specific IgG and IgA antibody levels indicative of chronic and active Chp infection.
  • Patients with high IgG and IgA levels exhibited significantly larger left ventricular end-diastolic (p=0.0005) and end-systolic (p=0.006) volumes at 10 weeks post-MI.

Conclusions:

  • Chronic Chlamydia pneumoniae infection significantly modifies the process of left ventricular remodeling after myocardial infarction.
  • Elevated Chp-specific antibodies are associated with adverse ventricular remodeling, suggesting a role for this infection in post-MI cardiac dysfunction.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...